1.7mg semaglutide Wegovy Flextouch (Semaglutide) Weight Loss Pen release injectable medication containing semaglutide Type 2 diabetes: New Ozempic

Do Not Use Mounjaro If You Have A personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 A serious allergic reaction to tirzepatide or any ingredient in Mounjaro Warnings and Precautions Mounjaro shares the same safety profile as Zepbound including warnings about pancreatitis, hypoglycemia (particularly with insulin or sulfonylureas), gallbladder disease, acute kidney injury, hypersensitivity reactions, severe GI disease, hormonal contraceptive interactions, diabetic retinopathy complications, and delayed gastric emptying increasing aspiration risk during anesthesia

There is a $10 service fee to have your referral money paid out

The Effectiveness of Semaglutide for Weight Loss In multiple large clinical trials with thousands of participants, semaglutide 2.4 mg led to substantial weight reduction: In a 68-week study of nearly 2000 adults, those getting semaglutide injections lost 14.9% body weight on average compared to 2.4% with placebo plus lifestyle intervention

All treatment decisions are made solely by your licensed provider